Research ArticleClinical Studies
Serum Soluble Interleukin-2 Receptor as a Potential Biomarker for Immune-related Adverse Events
RYO TAKAI, YOHEI FUNAKOSHI, HIROTAKA SUTO, YOSHIAKI NAGATANI, YOSHINORI IMAMURA, MASANORI TOYODA, KIMIKAZU YAKUSHIJIN, NAOMI KIYOTA, KEN-ICHI HARADA, KIMIHIRO YAMASHITA, YOSHIHIRO KAKEJI and HIRONOBU MINAMI
Anticancer Research February 2021, 41 (2) 1021-1026; DOI: https://doi.org/10.21873/anticanres.14857